Spearman’s correlation analysis revealed that glutamate exhibits robust positive associations with elevations in liver enzymes (ALT, AST, GGT), markers of insulin resistance (C-peptide, insulin), and adverse lipid profiles (triglycerides, LDL), highlighting its role as a key indicator of hepatic and metabolic dysfunction characteristic of MASLD. Here, GPT is linked to Insulin resistance.